SCDAA along with its members, advocates and champions received tremendous news during the Annual Sickle Cell Disease Advocacy Day. On the morning of Thursday - April 16, 2015 Representatives Danny K. Davis (D-IL) and Michael C. Burgess (R-TX) revealed the reintroduction of bipartisan legislation H.R. 1807
Breaking News: FDA Approves New Formulation of Iron Chelator
The US Food and Drug Administration (FDA) has approved a new oral formulation of deferasirox. The tablet will be marketed as Jadenu by Novartis, who also market Exjade, which has been the standard deferasirox formulation for the past 10 years.
FENDI teams with SCDAA in 3BAGUETTE PROJECT
FENDI presents the 3Baguette charity project in collaboration with the SCDAA's very own parent ambassador & model Jourdan Dunn, who has been invited by FENDI to personalize their own 3Baguette bag, allowing for a completely unique and fully interpreted creation that will be auctioned to benefit sickle cell disease!
2014 Black Celebrity Giving Cause Campaign Award Goes to the Sickle Cell Community
Vote for the Sickle Cell to Win The BCG Best Cause Campaign Award
Help the Sickle Cell Disease Association of America Win the 2014 Best Cause Campaign Award!
The SCDAA is honored to announce that we have been nominated for the Black Celebrity Giving 2014 Best Cause Campaign Award for our work on the White House Petition! We are once again requesting the help of the Sickle Cell Community to help make our campaign a success.
New report on Incidence of Sickle Cell Trait (SCT) & New Resources to Help
The sickle cell trait (SCT) toolkit is an online compilation of user friendly health education materials related to SCT. We are happy to have the opportunity to provide you or your organization with necessary tools and resources to educate yourself or the communities you serve about SCT. We hope that the information provided is both helpful and informative and empowers you or those you serve to take action